Follow
Sophie Riches
Sophie Riches
Unknown affiliation
Verified email at icr.ac.uk
Title
Cited by
Cited by
Year
Diffusion-weighted magnetic resonance imaging: a potential non-invasive marker of tumour aggressiveness in localized prostate cancer
NM Desouza, SF Riches, NJ Vanas, VA Morgan, SA Ashley, C Fisher, ...
Clinical radiology 63 (7), 774-782, 2008
3092008
Combined Use of Diffusion-Weighted MRI and 1H MR Spectroscopy to Increase Accuracy in Prostate Cancer Detection
SA Reinsberg, GS Payne, SF Riches, S Ashley, JM Brewster, VA Morgan, ...
American Journal of Roentgenology 188 (1), 91-98, 2007
2362007
A study of diffusion-weighted magnetic resonance imaging in men with untreated localised prostate cancer on active surveillance
NJ van As, NM de Souza, SF Riches, VA Morgan, SA Sohaib, ...
European urology 56 (6), 981-988, 2009
1892009
Diffusion‐weighted imaging of the prostate and rectal wall: comparison of biexponential and monoexponential modelled diffusion and associated perfusion coefficients
SF Riches, K Hawtin, EM Charles‐Edwards, NM De Souza
NMR in Biomedicine: An International Journal Devoted to the Development and …, 2009
1842009
Relationship between imaging biomarkers of stage I cervical cancer and poor-prognosis histologic features: quantitative histogram analysis of diffusion-weighted MR images
K Downey, SF Riches, VA Morgan, SL Giles, AD Attygalle, TE Ind, ...
American Journal of Roentgenology 200 (2), 314-320, 2013
1592013
MRI in the detection of prostate cancer: combined apparent diffusion coefficient, metabolite ratio, and vascular parameters
SF Riches, GS Payne, VA Morgan, S Sandhu, C Fisher, M Germuska, ...
American journal of roentgenology 193 (6), 1583-1591, 2009
1222009
Diffusion-weighted magnetic resonance imaging for monitoring prostate cancer progression in patients managed by active surveillance
VA Morgan, SF Riches, K Thomas, N Vanas, C Parker, S Giles, ...
The British journal of radiology 84 (997), 31-37, 2011
1092011
Nine-year follow-up for a study of diffusion-weighted magnetic resonance imaging in a prospective prostate cancer active surveillance cohort
DR Henderson, NM de Souza, K Thomas, SF Riches, VA Morgan, ...
European urology 69 (6), 1028-1033, 2016
832016
Diffusion-weighted MRI for locally recurrent prostate cancer after external beam radiotherapy
VA Morgan, SF Riches, S Giles, D Dearnaley, NM deSouza
American Journal of Roentgenology 198 (3), 596-602, 2012
822012
Apparent diffusion coefficient as a predictive biomarker of prostate cancer progression: value of fast and slow diffusion components
SL Giles, VA Morgan, SF Riches, K Thomas, C Parker, NM deSouza
American Journal of Roentgenology 196 (3), 586-591, 2011
722011
Relationship between T  2 relaxation and apparent diffusion coefficient in malignant and non-malignant prostate regions and the effect of peripheral zone fractional …
CJ Simpkin, VA Morgan, SL Giles, SF Riches, C Parker, NM DeSouza
The British Journal of Radiology 86 (1024), 20120469, 2013
462013
Measurements of occupational exposure to switched gradient and spatially‐varying magnetic fields in areas adjacent to 1.5 T clinical MRI systems
SF Riches, DJ Collins, GD Charles‐Edwards, JC Shafford, J Cole, ...
Journal of Magnetic Resonance Imaging: An Official Journal of the …, 2007
402007
Effect on therapeutic ratio of planning a boosted radiotherapy dose to the dominant intraprostatic tumour lesion within the prostate based on multifunctional MR parameters
SF Riches, GS Payne, NM Desouza, D Dearnaley, VA Morgan, ...
The British journal of radiology 87 (1037), 20130813, 2014
352014
EU Directive 2004/40: field measurements of a 1.5 T clinical MR scanner
SF Riches, DJ Collins, JW Scuffham, MO Leach
The British Journal of Radiology 80 (954), 483-487, 2007
352007
Multivariate modelling of prostate cancer combining magnetic resonance derived T2, diffusion, dynamic contrast-enhanced and spectroscopic parameters
SF Riches, GS Payne, VA Morgan, D Dearnaley, S Morgan, M Partridge, ...
European Radiology 25, 1247-1256, 2015
332015
Validation of T2-and diffusion-weighted magnetic resonance imaging for mapping intra-prostatic tumour prior to focal boost dose-escalation using intensity-modulated …
EJ Alexander, JR Murray, VA Morgan, SL Giles, SF Riches, S Hazell, ...
Radiotherapy and Oncology 141, 181-187, 2019
142019
Nine-year follow-up for a study of diffusion-weighted MRI in a prospective active surveillance cohort for prostate cancer.
DR Henderson, NM DeSouza, K Thomas, VA Morgan, SF Riches, ...
Journal of Clinical Oncology 33 (15_suppl), 5043-5043, 2015
22015
Optimal combined functional MR parameters to correctly identify tumour in the prostate
S Riches, GS Payne, M Partridge, C Jameson, V Morgan
Proc Intl Soc Mag Reson Med 44, 100, 2013
22013
Modelling Diffusion Data using a Stretched-Exponential Model: Pitfalls in Estimation Methodology
M Orton, D Collins, S Riches, M Leach
Prostate 1, 1.2, 2007
22007
Planning a boosted ra-diotherapy dose to the dominant intraprostatic tumour lesion within the prostate as defined by multifunctional MR parameters
SF Riches, GS Payne, NM DeSouza, S Morgan, D Dearnaley, V Morgan, ...
ISMRM, Salt Lake city, USA 100, 2013
12013
The system can't perform the operation now. Try again later.
Articles 1–20